Verastem Oncology (VSTM) Tops Q3 EPS by 8c
Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.71), $0.08 better than the analyst estimate of ($0.79).
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.71), $0.08 better than the analyst estimate of ($0.79).
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.